Latest Trading on NASDAQ

$135.73
1.52%
(-2.10)
Open 137.90
Previous Close 137.83
Today's Range
134.79 141.49
52 Week Range
67.98 144.00
Volume 379.90K
Avg. Volume (Weekly) 480.52K
Bid 130.00
Ask 137.95
Market Cap 4.21M
EPS -1.72
Shares Outstanding 31.05K
YTD High 141.49
Updated March 18, 2020

GW Pharmaceuticals PLC Sponsored ADR

U.K.-based GW Pharmaceuticals (“GW Pharma”) was formed in 1998 to develop cannabinoid based drugs. Much of its research and development efforts are focused on treatments for rare conditions stemming from epilepsy, glioma (a form of brain tumor), and schizophrenia.

GWPH Options Prices

Calls (Expiration: 01/22/2021)
Contract Name Strike Last Bid Ask Change %Chg Volume Open Int
GWPH210115C00040000 40.00 64.00 93.10 98.00 2.50 4.07% 4 5
GWPH210115C00045000 45.00 70.12 88.10 93.00 -9.68 -12.13% 9 7
GWPH210115C00050000 50.00 45.00 83.10 88.00 1.50 3.45% 1 2
GWPH210115C00055000 55.00 50.41 78.10 83.00 10.76 27.14% 2 24
GWPH210115C00060000 60.00 76.86 73.10 78.00 7.31 10.51% 3 9
GWPH210115C00065000 65.00 69.06 68.10 73.00 4.47 6.92% 2 8
GWPH210115C00070000 70.00 52.80 63.10 68.00 1.33 2.58% 1 47
GWPH210115C00075000 75.00 25.10 58.10 63.00 -0.60 -2.33% 1 41
GWPH210115C00080000 80.00 55.50 53.90 57.80 5.40 10.78% 1 156
GWPH210115C00085000 85.00 48.60 48.10 53.00 3.60 8.00% 1 16
GWPH210115C00090000 90.00 46.00 43.10 48.00 4.00 9.52% 1 71
GWPH210115C00095000 95.00 46.00 38.20 43.00 4.00 9.52% 2 176
GWPH210115C00100000 100.00 36.00 33.00 36.60 -0.48 -1.32% 8 262
GWPH210115C00105000 105.00 28.70 28.20 33.00 0.90 3.24% 12 82
GWPH210115C00110000 110.00 27.60 24.80 28.50 4.20 17.95% 4 461
GWPH210115C00115000 115.00 21.00 19.70 23.50 -2.00 -8.70% 404 843
GWPH210115C00120000 120.00 16.20 14.20 17.60 -2.30 -12.43% 636 2,376
GWPH210115C00125000 125.00 11.00 10.10 12.20 -1.70 -13.39% 530 1,019
GWPH210115C00130000 130.00 5.90 5.00 7.40 -1.60 -21.33% 438 863
GWPH210115C00135000 135.00 1.20 0.10 2.70 -2.64 -68.75% 104 499
GWPH210115C00140000 140.00 0.05 0.05 0.10 -0.84 -94.38% 113 1,754
GWPH210115C00145000 145.00 0.05 0.05 0.05 -0.15 -75.00% 4 1,498
GWPH210115C00150000 150.00 0.07 0.05 0.05 -0.02 -22.22% 6 823
GWPH210115C00155000 155.00 0.30 0.05 0.30 0.20 200.00% 10 84
GWPH210115C00160000 160.00 0.05 0.05 0.20 -0.15 -75.00% 1 291
GWPH210115C00165000 165.00 0.05 0.05 0.60 unch unch 52 190
GWPH210115C00170000 170.00 0.10 0.10 0.25 -0.20 -66.67% 3 160
GWPH210115C00175000 175.00 0.05 0.05 0.05 0.04 400.00% 30 169
GWPH210115C00180000 180.00 0.10 0.05 0.05 -0.08 -44.44% 337 865
GWPH210115C00185000 185.00 0.05 0.05 0.55 -0.77 -93.90% 2 21
GWPH210115C00190000 190.00 0.53 0.05 2.00 -0.02 -3.64% 3 59
GWPH210115C00195000 195.00 0.10 0.10 2.15 0.04 66.67% 1 24
GWPH210115C00200000 200.00 0.10 0.10 0.20 unch unch 2 124
GWPH210115C00210000 210.00 0.05 0.45 0.05 -0.10 -66.67% 15 41
GWPH210115C00220000 220.00 0.20 0.00 2.15 -0.08 -28.57% 1 108
GWPH210115C00230000 230.00 1.00 0.00 2.15 -0.30 -23.08% 1 12
GWPH210115C00240000 240.00 0.05 0.05 0.05 -0.11 -68.75% 1 99
GWPH210115C00250000 250.00 0.05 0.05 0.05 -0.10 -66.67% 100 232
GWPH210115C00260000 260.00 0.05 0.00 0.05 -0.13 -72.22% 5 246
GWPH210115C00270000 270.00 0.05 0.05 0.05 unch unch 1 111
Puts (Expiration: 01/22/2021)
Symbol Strike Last Bid Ask Change %Chg Volume Open Int
GWPH210115C00040000 40.00 64.00 93.10 98.00 2.50 4.07% 4 5
GWPH210115C00045000 45.00 70.12 88.10 93.00 -9.68 -12.13% 9 7
GWPH210115C00050000 50.00 45.00 83.10 88.00 1.50 3.45% 1 2
GWPH210115C00055000 55.00 50.41 78.10 83.00 10.76 27.14% 2 24
GWPH210115C00060000 60.00 76.86 73.10 78.00 7.31 10.51% 3 9
GWPH210115C00065000 65.00 69.06 68.10 73.00 4.47 6.92% 2 8
GWPH210115C00070000 70.00 52.80 63.10 68.00 1.33 2.58% 1 47
GWPH210115C00075000 75.00 25.10 58.10 63.00 -0.60 -2.33% 1 41
GWPH210115C00080000 80.00 55.50 53.90 57.80 5.40 10.78% 1 156
GWPH210115C00085000 85.00 48.60 48.10 53.00 3.60 8.00% 1 16
GWPH210115C00090000 90.00 46.00 43.10 48.00 4.00 9.52% 1 71
GWPH210115C00095000 95.00 46.00 38.20 43.00 4.00 9.52% 2 176
GWPH210115C00100000 100.00 36.00 33.00 36.60 -0.48 -1.32% 8 262
GWPH210115C00105000 105.00 28.70 28.20 33.00 0.90 3.24% 12 82
GWPH210115C00110000 110.00 27.60 24.80 28.50 4.20 17.95% 4 461
GWPH210115C00115000 115.00 21.00 19.70 23.50 -2.00 -8.70% 404 843
GWPH210115C00120000 120.00 16.20 14.20 17.60 -2.30 -12.43% 636 2,376
GWPH210115C00125000 125.00 11.00 10.10 12.20 -1.70 -13.39% 530 1,019
GWPH210115C00130000 130.00 5.90 5.00 7.40 -1.60 -21.33% 438 863
GWPH210115C00135000 135.00 1.20 0.10 2.70 -2.64 -68.75% 104 499
GWPH210115C00140000 140.00 0.05 0.05 0.10 -0.84 -94.38% 113 1,754
GWPH210115C00145000 145.00 0.05 0.05 0.05 -0.15 -75.00% 4 1,498
GWPH210115C00150000 150.00 0.07 0.05 0.05 -0.02 -22.22% 6 823
GWPH210115C00155000 155.00 0.30 0.05 0.30 0.20 200.00% 10 84
GWPH210115C00160000 160.00 0.05 0.05 0.20 -0.15 -75.00% 1 291
GWPH210115C00165000 165.00 0.05 0.05 0.60 unch unch 52 190
GWPH210115C00170000 170.00 0.10 0.10 0.25 -0.20 -66.67% 3 160
GWPH210115C00175000 175.00 0.05 0.05 0.05 0.04 400.00% 30 169
GWPH210115C00180000 180.00 0.10 0.05 0.05 -0.08 -44.44% 337 865
GWPH210115C00185000 185.00 0.05 0.05 0.55 -0.77 -93.90% 2 21
GWPH210115C00190000 190.00 0.53 0.05 2.00 -0.02 -3.64% 3 59
GWPH210115C00195000 195.00 0.10 0.10 2.15 0.04 66.67% 1 24
GWPH210115C00200000 200.00 0.10 0.10 0.20 unch unch 2 124
GWPH210115C00210000 210.00 0.05 0.45 0.05 -0.10 -66.67% 15 41
GWPH210115C00220000 220.00 0.20 0.00 2.15 -0.08 -28.57% 1 108
GWPH210115C00230000 230.00 1.00 0.00 2.15 -0.30 -23.08% 1 12
GWPH210115C00240000 240.00 0.05 0.05 0.05 -0.11 -68.75% 1 99
GWPH210115C00250000 250.00 0.05 0.05 0.05 -0.10 -66.67% 100 232
GWPH210115C00260000 260.00 0.05 0.00 0.05 -0.13 -72.22% 5 246
GWPH210115C00270000 270.00 0.05 0.05 0.05 unch unch 1 111
Show more

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company’s lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.